News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

The results of this first-in-human study of CAN-3110 demonstrate a median overall survival that was substantially longer than the six to nine months typically observed in recurrent high-grade glioma as well as a favorable safety profile.

https://www.businesswire.com/news/home/20210604005138/en/Candel-Therapeutics-Announces-Data-from-Phase-1-Trial-of-CAN-3110-in-Recurrent-High-Grade-Glioma-at-the-2021-American-Society-of-Clinical-Onc…

Looking forward to presenting an overview of Candel Therapeutics at the upcoming Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 1:30 PM ET.

https://www.businesswire.com/news/home/20210527005135/en/Candel-Therapeutics-to-Present-at-Upcoming-Jefferies-Virtual-Healthcare-Conference

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors. Her strategic insights will be key as we advance our late stage pipeline of agents with the potential to bec…

Prof Paul Peter Tak: Rheumatology, Real Impact and Comfort Zones

Prof Paul Peter Tak is my guest on the podcast this week. He talks to me about growing up in the Netherlands. his medical career and how he ended up specializing in Rheumatology. We chat about his i…

The Story of Flagship Pioneering and The Future of Medicines

James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics. Over a more than 25-year career in the life sciences, Paul-Peter has created and le…

Careers in Discovery

Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influen…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.